Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients

Carcinogenesis(2022)10.1093/carcin/bgac092Source: DataRank Database

Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patients is a research paper published in Carcinogenesis (2022). On theSindex it has a DataRank of 0. It has been cited 55 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access55 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 4.47)OA: hybridTopics (29)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Wei Tang ORCID,Azadeh Azizian ORCID,Jochen Gaedcke ORCID,Philipp Ströbel ORCID,Limin Wang ORCID

Live enrichment

PubMed:36426859 OpenAlex:https://openalex.org/W4310053719

FWCI

4.47

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

hybridLicense: public-domain

journalhttps://academic.oup.com/carcin/article-pdf/43/12/1198/50064876/bgac092.pdf

publisherhttps://academic.oup.com/carcin/article-pdf/43/12/1198/50064876/bgac092.pdf

publisherhttps://academic.oup.com/carcin/advance-article-pdf/doi/10.1093/carcin/bgac092/48786951/bgac092.pdf

journalhttps://doi.org/10.1093/carcin/bgac092

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36426859

Fields of Study

Clusterin in disease pathologyPancreatic and Hepatic Oncology ResearchFerroptosis and cancer prognosis

MeSH Terms

GemcitabineAnimalsHumansPancreatic NeoplasmsGene Expression Regulation, NeoplasticDisease ProgressionCarcinoma, Pancreatic DuctalCell Line, TumorClusterinMiceHepatocyte Nuclear Factor 1-betaEpithelial-Mesenchymal Transition

Keywords

ClusterinPancreatic cancerCancer researchCancerMedicineGemcitabineOncologyHNF1BGene signatureInternal medicineBiologyGene expressionApoptosisGene

Sustainable Development Goals

SDG 0: Good health and well-being